101 - 125 of 6516 Results
Title
Year
-
OPENTitle: The neuro-toxin MPTP does not prevent reproduction in marmosetsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.12688/mniopenres.12818.1Best OA location URL: https://mniopenresearch.org/articles/3-2/v1/pdfCitation Count: 0
-
OPENTitle: Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fneur.2021.656342Best OA location URL: https://doi.org/10.3389/fneur.2021.656342Citation Count: 6
-
OPENTitle: LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic InsightsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 1Start Page: 169End Page: 169Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/cells11010169Best OA location URL: https://www.mdpi.com/2073-4409/11/1/169/pdf?version=1641527866Citation Count: 34
-
OPENTitle: Editorial: Non-neuronal cell heterogeneity in the nervous system during health and diseaseJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.1047296Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.1047296/pdfCitation Count: 1
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://doi.org/10.3389/fnmol.2021.721749Citation Count: 15
-
OPENTitle: Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 4Start Page: 381End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00377-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8985079Citation Count: 220
-
OPENTitle: Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulationJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.1084782Best OA location URL: https://escholarship.org/uc/item/6jh798dxCitation Count: 22
-
OPENTitle: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 83Issue #: 5Start Page: 389End Page: 402Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40265-023-01838-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-023-01838-z.pdfCitation Count: 32
-
OPENTitle: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s SymptomsJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 19Issue #: 1Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph19010364Best OA location URL: https://www.mdpi.com/1660-4601/19/1/364/pdf?version=1641285359Citation Count: 67
-
OPENTitle: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29707Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29707Citation Count: 21
-
OPENTitle: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 669End Page: 683Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28941Citation Count: 78
-
OPENTitle: Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network ApproachJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page: 1511End Page: 1527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30231Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30231Citation Count: 0
-
OPENTitle: Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific researchJournal Name: Insights into ImagingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13244-024-01848-9Best OA location URL: https://insightsimaging.springeropen.com/counter/pdf/10.1186/s13244-024-01848-9Citation Count: 1
-
OPENTitle: Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbationsJournal Name: Aging CellPublisher: WileyVol: 21Issue #: 5Start Page: e13606End Page: e13606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13606Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13606Citation Count: 52
-
OPENTitle: Radioligands Targeting the Purinergic P2X ReceptorsJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 13Start Page: 984End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14130984Best OA location URL: https://www.mdpi.com/2073-4409/14/13/984/pdf?version=1751010309Citation Count: 0
-
OPENTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 266
-
OPENTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 7
-
OPENTitle: Initiation and propagation of α-synuclein aggregation in the nervous systemJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 19End Page: 19Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00368-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00368-6Citation Count: 245
-
OPENTitle: Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and RecommendationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 175End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13586Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9941935Citation Count: 6
- Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective2022OPENTitle: Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspectiveJournal Name: Animal Models and Experimental MedicinePublisher: WileyVol: 5Issue #: 1Start Page: 27End Page: 37Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ame2.12209Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ame2.12209Citation Count: 26
-
OPENTitle: Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 12Issue #: 6Start Page: 1494End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2021.0527Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=148118Citation Count: 47
-
OPENTitle: Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseasesJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 117Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jleuko/qiaf154Best OA location URL: https://academic.oup.com/jleukbio/advance-article-pdf/doi/10.1093/jleuko/qiaf154/65038951/qiaf154.pdfCitation Count: 0
-
OPENTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7448947Citation Count: 49
-
OPENTitle: Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative DiseasesJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 32Issue #: 12Start Page: 817End Page: 833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/ars.2019.7916Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7074890Citation Count: 52
-
OPENTitle: Vesicle trafficking and lipid metabolism in synucleinopathyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 4Start Page: 491End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02177-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7772270Citation Count: 43